Is Aeon Biopharma Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NYSEMKT: AEON) stock is to Strong Buy AEON stock.
Out of 1 analyst, 1 (100%) are recommending AEON as a Strong Buy, 0 (0%) are recommending AEON as a Buy, 0 (0%) are recommending AEON as a Hold, 0 (0%) are recommending AEON as a Sell, and 0 (0%) are recommending AEON as a Strong Sell.
What is AEON's forecast return on equity (ROE) for 2025-2028?
(NYSEMKT: AEON) forecast ROE is -121.63%, which is considered weak.
What is AEON's Price Target?
According to 1 Wall Street analyst that have issued a 1 year AEON price target, the average AEON price target is $7.20, with the highest AEON stock price forecast at $7.20 and the lowest AEON stock price forecast at $7.20.
The Wall Street analyst predicted that Aeon Biopharma's share price could reach $7.20 by Oct 8, 2026. The average Aeon Biopharma stock price prediction forecasts a potential upside of 554.55% from the current AEON share price of $1.10.
What is AEON's forecast return on assets (ROA) for 2025-2028?
(NYSEMKT: AEON) forecast ROA is 165.33%, which is higher than the forecast US Biotechnology industry average of 35.83%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.